JO
FHTX icon

John Overdeck’s Foghorn Therapeutics FHTX Stock Holding History

John Overdeck’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7K Buy
+12,445
New +$55.2K ﹤0.01% 4941
2026
Q1 		– Sell
-16,600
Closed -$89.6K – 4687
2025
Q4 		$89.6K Buy
+16,600
New +$75.3K ﹤0.01% 3866

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

John Overdeck's FHTX Position: Q2 2026 in Review

John Overdeck opened a new position in Foghorn Therapeutics (FHTX) in Q2 2026: 12,445 shares worth $60.7K. The stake represents ﹤0.01% of the portfolio and ranks #4941 among its holdings. This is a return to the name: John Overdeck previously reported a position in FHTX as recently as Q4 2025.

John Overdeck first reported a position in FHTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $89.6K in Q4 2025. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • John Overdeck held 12,445 shares of Foghorn Therapeutics worth $60.7K as of Q2 2026.
  • Foghorn Therapeutics was a new John Overdeck position in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4941 holding.
  • John Overdeck first reported a position in Foghorn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • John Overdeck's Foghorn Therapeutics position peaked at $89.6K in Q4 2025.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.